REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 211 filers reported holding REGENXBIO INC in Q1 2019. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $718,000 | -28.9% | 17,528 | -38.2% | 0.01% | -31.2% |
| Q3 2019 | $1,010,000 | -25.3% | 28,354 | +7.7% | 0.02% | -27.3% |
| Q2 2019 | $1,352,000 | +231.4% | 26,333 | +270.3% | 0.02% | +175.0% |
| Q1 2019 | $408,000 | -55.8% | 7,111 | -67.7% | 0.01% | -61.9% |
| Q4 2018 | $924,000 | -45.6% | 22,010 | -2.1% | 0.02% | -34.4% |
| Q3 2018 | $1,697,000 | -0.7% | 22,482 | -5.6% | 0.03% | -23.8% |
| Q2 2018 | $1,709,000 | – | 23,817 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
| Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
| ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
| Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
| RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
| WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
| FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
| Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
| Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
| HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |